发明公开
EP1326857A2 DIAZACYCLOALKANEDIONE DERIVATIVES WHICH ARE USEFUL AS LFA-1 ANTAGONISTS
审中-公开
DIAZACYCLOALKANDIONE,作为LFA-1拮抗剂能有效
- 专利标题: DIAZACYCLOALKANEDIONE DERIVATIVES WHICH ARE USEFUL AS LFA-1 ANTAGONISTS
- 专利标题(中): DIAZACYCLOALKANDIONE,作为LFA-1拮抗剂能有效
-
申请号: EP01980462.4申请日: 2001-10-01
-
公开(公告)号: EP1326857A2公开(公告)日: 2003-07-16
- 发明人: ALBERT, Rainer , DAWSON KING, Janet , EHRHARDT, Claus , WATTANASIN, Sompong , WEITZ SCHMIDT, Gabriele , WELZENBACH, Karl
- 申请人: Novartis AG , Novartis Pharma GmbH
- 申请人地址: Lichtstrasse 35 4002 Basel CH
- 专利权人: Novartis AG,Novartis Pharma GmbH
- 当前专利权人: Novartis AG,Novartis Pharma GmbH
- 当前专利权人地址: Lichtstrasse 35 4002 Basel CH
- 代理机构: Gros, Florent
- 优先权: US237231P 20001002
- 国际公布: WO02028842 20020411
- 主分类号: C07D401/06
- IPC分类号: C07D401/06
摘要:
Compounds of formula (I) wherein R is carboxy, esterified carboxy or amidated carboxy; R1 and R3 are independently lower alkyl, (hydroxy, lower alkoxy, amino, acylamino, mono- or di- lower alkylamino or mercapto)-lower alkyl, lower alkyl-(thio, sulfinyl or sulfonyl)-lower alkyl, cycloalkyl, aryl, biaryl, (cycloalkyl, aryl or biaryl)-lower alkyl, or (carboxy, esterified carboxy or amidated carboxy)-lower alkyl; R2 is hydrogen, lower alkyl, cycloalkyl, aryl, biaryl, arylaminocarbonyl, or aryl-(oxy, thio or amino); n is 1 or 2; Y is lower-alkylene or lower alkenylene; and pharmaceutically acceptable salts thereof; which are useful as LFA-1 antagonists.
信息查询